| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-11-17 | Rubric Capital Management LP | TherapeuticsMD, Inc. | 2,946,908 | 25.7% | EDGAR |
| SC 13D/A | 2023-06-30 | Rubric Capital Management LP | TherapeuticsMD, Inc. | 2,069,716 | 19.6% | EDGAR |
| SC 13D/A | 2022-08-30 | Rubric Capital Management LP | TherapeuticsMD, Inc. | 1,721,953 | 18.3% | EDGAR |
| SC 13D | 2022-08-08 | Rubric Capital Management LP | TherapeuticsMD, Inc. | 1,721,953 | 18.3% | EDGAR |
| SC 13G/A | 2022-07-08 | BlackRock Inc. | TherapeuticsMD, Inc. | 122,138 | 1.4% | EDGAR |
| SC 13G | 2022-06-03 | Beryl Capital Management LLC | TherapeuticsMD, Inc. | 126,229 | 1.5% | EDGAR |
| SC 13D/A | 2022-03-23 | SMITH ROBERT J | TherapeuticsMD, Inc. | 23,103,292 | - | EDGAR |
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | TherapeuticsMD, Inc. | 649,807 | 0.1% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | TherapeuticsMD, Inc. | 24,894,812 | 5.9% | EDGAR |
| SC 13G | 2021-07-07 | Flynn James E | TherapeuticsMD, Inc. | 20,662,810 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | TherapeuticsMD, Inc. | 18,869,212 | 6.2% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | TherapeuticsMD, Inc. | 13,165,644 | 4.4% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | TherapeuticsMD, Inc. | 14,116,461 | 4.7% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | TherapeuticsMD, Inc. | 21,419,273 | 7.1% | EDGAR |
| SC 13G/A | 2020-12-09 | JPMORGAN CHASE & CO | TherapeuticsMD, Inc. | 13,079,428 | 4.3% | EDGAR |
| SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | TherapeuticsMD, Inc. | 19,239,545 | 7.0% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | TherapeuticsMD, Inc. | 16,595,225 | 6.1% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | TherapeuticsMD, Inc. | 17,677,475 | 6.5% | EDGAR |
| SC 13G/A | 2020-02-06 | BlackRock Inc. | TherapeuticsMD, Inc. | 18,259,143 | 6.7% | EDGAR |
| SC 13G/A | 2020-01-21 | JPMORGAN CHASE & CO | TherapeuticsMD, Inc. | 19,718,046 | 7.2% | EDGAR |